O36.113 Maternal care for Anti-A sensitization, third trimester

Name of the Condition

• Maternal care for Anti-A sensitization, third trimester
• ICD Code: O36.113

Summary

This condition involves medical care and monitoring provided to a pregnant woman who has developed antibodies against the A antigen on red blood cells during the third trimester. The care focuses on managing the potential risks to the fetus and ensuring maternal health during pregnancy, particularly addressing the risk of hemolytic disease of the fetus and newborn (HDFN).

Causes

Anti-A sensitization occurs when an individual with type O blood (lacking A antigens) is exposed to A-positive blood, triggering the production of anti-A antibodies. In pregnancy, this exposure may happen during a previous pregnancy with an A-positive fetus, blood transfusion, or events causing fetal-maternal blood mixing. These antibodies can cross the placenta and attack the red blood cells of an A-positive fetus.

Risk Factors

• Previous pregnancy with an A-positive fetus
• Blood transfusion with A-positive blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., amniocentesis)
• Prior miscarriage or ectopic pregnancy involving an A-positive fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn

Diagnosis

Diagnosis involves blood typing and antibody screening to detect anti-A antibodies. Doppler ultrasound may be used to assess fetal blood flow and anemia. Amniocentesis or cordocentesis may be performed to evaluate fetal hemolysis and anemia severity.

Treatment Options

Treatment may include close monitoring of fetal well-being, such as serial ultrasounds and non-stress tests. In severe cases, intrauterine transfusion of red blood cells to the fetus may be necessary. Post-delivery care for the newborn may involve phototherapy or exchange transfusion to manage jaundice.

Prognosis and Follow-Up

With appropriate monitoring and intervention, outcomes for both mother and fetus are generally favorable. Follow-up care includes continued monitoring of the newborn for signs of anemia or jaundice and ensuring maternal recovery post-delivery.

Complications

Potential complications include fetal anemia, hydrops fetalis, preterm birth, and neonatal jaundice requiring intensive care. Severe cases may lead to fetal demise if not managed promptly.

Lifestyle & Prevention

Preventive measures include avoiding unnecessary blood transfusions with incompatible blood types and minimizing invasive procedures during pregnancy to reduce fetal-maternal blood mixing. Prenatal care should emphasize early detection and management of sensitization.

When to Seek Professional Help

Seek immediate medical attention if there are signs of fetal distress (e.g., reduced fetal movement), severe abdominal pain, or symptoms of preterm labor. Regular prenatal visits are essential for monitoring and early intervention.

Tips for Medical Coders

Document the trimester of sensitization and any associated monitoring or interventions. Ensure the code O36.113 is used when care is specifically for Anti-A sensitization in the third trimester. Include details of fetal monitoring, transfusions, or other treatments to support medical necessity.